Skip to main content
Year archive

HLB Life Science CO.,LTD. — 2023 filings

All 61 regulatory filings released by HLB Life Science CO.,LTD. (067630) in 2023, sourced directly from the official regulator.

61 Filings
2023 Period
2023 filings (61)
Filing Released Lang
투자판단관련주요경영사항(리보세라닙 식품의약품안전처 국내 조건부 품목허가 신청 자진 취하)
Regulatory Filings
2023-12-15 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-12-14 Korean
가족친화인증ㆍ유효기간연장ㆍ인증취소(자율공시)
Environmental & Social Information
2023-12-01 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-11-17 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-11-14 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2023-11-07 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2023-11-07 Korean
증권발행결과(자율공시)
Capital/Financing Update
2023-11-07 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-10-25 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-10-25 Korean
[기재정정]주요사항보고서(회사분할결정)
M&A Activity
2023-10-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-10-13 Korean
전환가액의조정
Share Issue/Capital Change
2023-10-10 Korean
합병등종료보고서(합병)
M&A Activity
2023-10-04 Korean
[기재정정]주요사항보고서(회사분할결정)
M&A Activity
2023-10-04 Korean
[기재정정]주주총회소집결의
AGM Information
2023-10-04 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-10-04 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity
2023-09-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-09-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-09-22 Korean
주요사항보고서(회사분할결정)
M&A Activity
2023-09-18 Korean
주주총회소집결의
AGM Information
2023-09-18 Korean
신주인수권행사가액의조정
Share Issue/Capital Change
2023-09-14 Korean
[기재정정]사업보고서 (2022.12)
Annual Report FY 2022
2023-08-31 Korean
기타경영사항(자율공시)(소규모합병 승인 이사회결의(주주총회 갈음) 결과 보고)
M&A Activity
2023-08-24 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-11 Korean
주요사항보고서(회사합병결정)
M&A Activity
2023-07-18 Korean
주주명부폐쇄기간또는기준일설정
M&A Activity
2023-07-18 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-07-07 Korean
증권발행결과(자율공시)
Capital/Financing Update
2023-07-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-07-05 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2023-07-04 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2023-06-29 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-12 Korean
기업설명회(IR)개최
Report Publication Announcement
2023-05-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-04-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-04-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-04-07 Korean
신주인수권행사가액의조정
Share Issue/Capital Change
2023-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2023-03-31 Korean
[기재정정]신주인수권행사가액의조정
Share Issue/Capital Change
2023-03-31 Korean
[기재정정]주주총회소집공고
AGM Information
2023-03-24 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-03-24 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-23 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-03-23 Korean
[기재정정]주주총회소집공고
AGM Information
2023-03-23 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-03-21 Korean
투자판단관련주요경영사항(파이로티닙의 제3상 임상시험계획 승인 )
Legal Proceedings Report
2023-03-21 Korean
신주인수권행사가액의조정
Share Issue/Capital Change
2023-03-14 Korean
주주총회소집결의
AGM Information
2023-02-24 Korean
주주총회집중일개최사유신고
AGM Information
2023-02-24 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-02-24 Korean
주주총회소집공고
AGM Information
2023-02-24 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-02-10 Korean
투자판단관련주요경영사항(리보세라닙 식품의약품안전처 국내 조건부 품목허가 신청)
Regulatory Filings
2023-02-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-01-04 Korean
전환가액의조정
Share Issue/Capital Change
2023-01-02 Korean